BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17709533)

  • 1. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice.
    Fang C; Miwa T; Shen H; Song WC
    J Immunol; 2007 Sep; 179(5):3178-86. PubMed ID: 17709533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T cell memory in B cell-deficient mice.
    Asano MS; Ahmed R
    J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell memory. Long-term persistence of virus-specific cytotoxic T cells.
    Jamieson BD; Ahmed R
    J Exp Med; 1989 Jun; 169(6):1993-2005. PubMed ID: 2471771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40L expression by CD4
    Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
    Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual LCMV antigen in transiently CD4
    Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
    Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
    Suresh M; Gao X; Fischer C; Miller NE; Tewari K
    J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection.
    Selin LK; Welsh RM
    J Immunol; 1997 Jun; 158(11):5366-73. PubMed ID: 9164957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation.
    Raedler H; Yang M; Lalli PN; Medof ME; Heeger PS
    Am J Transplant; 2009 Aug; 9(8):1784-95. PubMed ID: 19563342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
    Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
    Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression.
    Fung-Leung WP; Kündig TM; Zinkernagel RM; Mak TW
    J Exp Med; 1991 Dec; 174(6):1425-9. PubMed ID: 1683893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
    Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
    J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
    Bao L; Haas M; Minto AW; Quigg RJ
    Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
    Borrow P; Tishon A; Oldstone MB
    J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
    Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
    J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.